Certain Intravascular Administration Sets and Components Thereof Institution of Investigation

Notice is hereby given that a complaint was filed with the U.S. International Trade Commission on March 13, 2017, under section 337 of the Tariff Act of 1930, as amended, on behalf of Curlin Medical Inc. of East Aurora, New York; ZEVEX, Inc. of Salt Lake City, Utah; and Moog Inc. of East Aurora, New York. The complaint alleges violations of section 337 based upon the importation into the United States, the sale for importation, and the sale within the United States after importation of certain intravascular administration sets and components thereof by reason of infringement of certain claims of U.S. Patent No. 6,164,921 (``the '921 patent'') and U.S. Patent No. 6,371,732 (``the '732 patent''). The complaint further alleges that an industry in the United States exists as required by the applicable Federal Statute. The complainants request that the Commission institute an investigation and, after the investigation, issue a limited exclusion order and a cease and desist order.